Risk factors for thromboembolic events in testicular cancer patients receiving chemotherapy

被引：0
|
作者：
Shim, K.
Potvin, K. R.
Mills, K.
Whiston, F.
Stitt, L.
Winquist, E.
机构：
[1] London Reg Canc Program, London, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16109
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk factors for thromboembolic events in patients with testicular cancer
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (04) : 191 - 191
  • [2] A new generic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy
    Munoz, A.
    Ziyatdinov, A.
    Souto, J. C.
    Soria, J. M.
    Soria, J. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 554 - 555
  • [3] A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy
    Munoz Martin, A. J.
    Ziyatdinov, A.
    Castellon Rubio, V.
    Pachon Olmos, V.
    Morejon Huerta, B.
    Calzas Rodriguez, J.
    Salgado Fernandez, M.
    Martinez de Castro, E.
    Luque Caro, R.
    Soria Fernandez, J. M.
    [J]. THROMBOSIS RESEARCH, 2016, 140 : S177 - S178
  • [4] Risk factors for venous thromboembolic events in cancer patients
    Kleeberg, Ulrich R.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (11) : 689 - 690
  • [5] Risk factors for venous thromboembolic events in cancer patients
    Kröger, K
    Weiland, D
    Ose, C
    Neumann, N
    Weiss, S
    Hirsch, C
    Urbanski, K
    Seeber, S
    Scheulen, ME
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (02) : 297 - 303
  • [6] Venous thromboembolic events in early breast cancer patients receiving chemotherapy in India
    Chauhan, V. S.
    Pathak, B. D.
    [J]. BREAST, 2015, 24 : S74 - S75
  • [7] Semuloparin Helps Prevent Thromboembolic Events in Patients Receiving Chemotherapy
    不详
    [J]. ONCOLOGY-NEW YORK, 2012, 26 (03): : 258 - +
  • [8] Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
    Tebbutt, N. C.
    Murphy, F.
    Zannino, D.
    Wilson, K.
    Cummins, M. M.
    Abdi, E.
    Strickland, A. H.
    Lowenthal, R. M.
    Marx, G.
    Karapetis, C.
    Shannon, J.
    Goldstein, D.
    Nayagam, S. S.
    Blum, R.
    Chantrill, L.
    Simes, R. J.
    Price, T. J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1834 - 1838
  • [9] Chemotherapy-induced hypercoagulability and biomarkers for prediction of thromboembolic events in patients with metastatic testicular cancer
    Lubberts, S.
    Boer, H.
    Altena, R.
    Meijer, C.
    Lefrandt, J. D.
    Nuver, J.
    Mulder, A. B.
    Lisman, T.
    Kamphuisen, P. W.
    Gietema, J. A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 94 - 95
  • [10] Thromboembolic events in patients with melanoma receiving immune checkpoint inhibitors: Incidence and risk factors
    van Dorst, D.
    Hofman, M. M.
    de Waal, R. M.
    Oomen-de Hoop, E.
    Joode, K. D.
    Bins, S.
    Koolen, S. L.
    Joosse, A.
    Versmissen, J.
    Van der Veldt, A. A. M.
    Mathijssen, R. H.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S689 - S689
12345